title: [Spleen-preserving D2-lymphodissection in gastric cancer surgery].
abstract: Oncological advisability of spleen removal during surgical treatment of gastric cancer is arguable at present time. It is presented technique of spleen-preserving D2-lymphodissection used for gastric body and proximal part cancer which was applied in 155 patients. Control group included 197 patients who underwent gastrectomy with splenectomy. Spleen-preserving D2-lymphodissection increased duration of surgery but decreased frequency of subdiaphragmatic abscess and pancreatic fistulas and duration of hospital stay. 5-years survival (Kaplan-Meier) was 59% in main group, in control group - 55% (p>0.05). We consider that spleen-preserving D2-lymphodissection is radical and safe surgical method for locally advanced cancer of gastric body and proximal part.
authors.affiliation: Rossiĭskiĭ onkologicheskiĭ nauchnyĭ tsentr im. N.N. Blokhina RAMN, Moskva.
authors.forename: I S
authors.initials: IS
authors.lastname: Stilidi
authors.affiliation: Rossiĭskiĭ onkologicheskiĭ nauchnyĭ tsentr im. N.N. Blokhina RAMN, Moskva.
authors.forename: S N
authors.initials: SN
authors.lastname: Nered
authors.affiliation: Rossiĭskiĭ onkologicheskiĭ nauchnyĭ tsentr im. N.N. Blokhina RAMN, Moskva.
authors.forename: E V
authors.initials: EV
authors.lastname: Glukhov
mesh_terms: D005260:Female; D006801:Humans; D008197:Lymph Node Excision / Q000379:methods*; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D009031:Moscow; D009367:Neoplasm Staging; D059351:Organ Sparing Treatments / Q000379:methods; D011183:Postoperative Complications / Q000209:etiology / Q000517:prevention & control*; D011379:Prognosis; D012189:Retrospective Studies; D013154:Spleen / Q000473:pathology; D013156:Splenectomy / Q000009:adverse effects* / Q000379:methods; D013270:Stomach / Q000473:pathology / Q000601:surgery; D013274:Stomach Neoplasms / Q000473:pathology / Q000601:surgery; D015996:Survival Rate; D016896:Treatment Outcome